India, Nov. 19 -- By now, everyone has heard of GLP-1 wonder drugs like Ozempic and Zepbound. They show up in Bollywood interviews, influencer reels, and real medical conversations. Their posters are plastered all over airports.

Semaglutide belongs to this class of drugs. They were initially developed to control blood sugar in diabetics, but researchers noticed something unexpected: they also triggered substantial weight loss and appeared to protect against heart attacks and strokes. The medical community assumed this cardiovascular benefit came from weight loss. Obesity strains the heart, raises blood pressure, and promotes inflammation. Initially, marketed as diabetes treatment.

A medical analysis published in The Lancet last month gi...